DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Maraveyas A, Sgouros J, Upadhyay S. et al.
Gemcitabine twice weekly as a radiosensitiser for the treatment of brain
metastases in patients with carcinoma: a phase I study.
Br J Cancer 2005;
92: 815-819
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.